TIRZEE 15MG/0.5ML Prefilled Pen by Getz Pharma contains Tirzepatide, a prescription injectable medicine used as part of a healthcare professional's treatment plan for appropriate patients with type 2 diabetes and/or chronic weight management, depending on the approved indication and prescribing guidance.
Tirzepatide is a dual GIP and GLP-1 receptor agonist that works on hormonal pathways involved in blood glucose regulation, appetite, and food intake. It can help improve blood sugar control and, when prescribed for weight management, support clinically meaningful weight reduction alongside a reduced-calorie diet and increased physical activity.
TIRZEE 15MG/0.5ML is a temperature-sensitive medicine. For product quality and safe handling, this product is only deliverable in Lahore through SuperCare Pharma.
Use TIRZEE only under the supervision and prescription of a qualified healthcare professional.
TIRZEE 15MG/0.5ML Prefilled Pen is a prescription injectable formulation containing Tirzepatide.
The 15mg strength is generally used as part of a structured dose-escalation treatment plan when prescribed by a healthcare professional. It is not usually the starting strength.
Tirzepatide activates both GIP and GLP-1 receptors, providing complementary effects on glucose regulation and appetite.
For appropriate patients with type 2 diabetes, Tirzepatide can help lower blood glucose and improve glycemic control as part of an overall treatment plan.
Tirzepatide can reduce appetite and food intake and may support significant weight loss when prescribed for appropriate patients alongside lifestyle changes.
The medicine acts on hormone pathways involved in appetite and satiety, potentially helping patients feel fuller and reduce food intake.
Tirzepatide is administered once weekly, according to the prescribed treatment schedule.
The prefilled pen provides a ready-to-use injection format when used according to the manufacturer's instructions.
TIRZEE provides a 15mg/0.5mL Tirzepatide strength for patients whose healthcare professional has prescribed this dose.
TIRZEE contains Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
Tirzepatide activates GIP and GLP-1 receptors involved in blood glucose regulation and appetite control.
Tirzepatide helps increase insulin secretion in a glucose-dependent manner and can reduce glucagon secretion when glucose levels are elevated. This helps improve blood glucose control in appropriate patients with type 2 diabetes.
Tirzepatide also affects appetite-related pathways and can reduce food intake. It may slow gastric emptying, particularly during treatment initiation, contributing to increased feelings of fullness.
Depending on the applicable prescribing indication, Tirzepatide may be used as part of a treatment plan for:
Tirzepatide is not intended for people with type 1 diabetes and should not be used as a substitute for insulin.
Always follow your doctor's diagnosis and prescription.
TIRZEE may be prescribed for eligible patients based on their medical condition and treatment goals.
Your healthcare professional may consider:
The 15mg strength should only be used when specifically prescribed. Patients generally reach higher Tirzepatide strengths through gradual dose escalation rather than starting directly at 15mg.
| Active Ingredient | Strength | Function |
|---|---|---|
| Tirzepatide | 15mg/0.5mL | Dual GIP and GLP-1 receptor agonist that helps regulate blood glucose, appetite, and food intake |
TIRZEE is administered as a subcutaneous injection once weekly according to your healthcare professional's instructions.
It may be injected under the skin of the:
If you miss a scheduled dose of Tirzepatide, follow the instructions provided by your healthcare professional or the product's approved prescribing information.
Do not take extra doses to compensate for a missed injection.
If you are unsure what to do after missing a dose, contact your doctor or pharmacist before taking the next injection.
Like all medicines, Tirzepatide can cause side effects.
Gastrointestinal effects are among the most commonly reported, including:
These effects may be more noticeable during dose escalation and may improve as the body adjusts to treatment.
Tirzepatide may also be associated with:
Seek medical attention for severe or persistent symptoms.
Before using TIRZEE, inform your healthcare provider if you:
Tirzepatide can cause significant gastrointestinal symptoms and dehydration, which may affect kidney function in susceptible patients.
Tirzepatide carries an important warning regarding thyroid C-cell tumors based on findings from animal studies.
Tell your doctor if you or a family member has a history of medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tirzepatide should not be used in patients with a personal or family history of MTC or in patients with MEN 2 where contraindicated by the applicable product labeling.
Tirzepatide can increase the risk of low blood sugar (hypoglycemia), particularly when used together with insulin or medicines such as sulfonylureas.
Symptoms may include:
Your healthcare professional may adjust other diabetes medicines to reduce this risk.
Severe and persistent abdominal pain, especially if it radiates to the back and is accompanied by vomiting, may be a sign of acute pancreatitis.
Stop using the medicine and seek urgent medical attention if you develop symptoms suggestive of pancreatitis.
Tirzepatide treatment may be associated with gallbladder-related problems, including gallstones or inflammation of the gallbladder.
Seek medical advice if you develop:
Severe vomiting or diarrhea can lead to dehydration and may worsen kidney function, particularly in patients who already have kidney problems.
Drink adequate fluids as advised by your healthcare professional and contact your doctor if severe gastrointestinal symptoms occur.
Tell your doctor about all medicines you are taking, particularly:
Tirzepatide can slow gastric emptying and may affect the absorption of some oral medicines.
Do not combine TIRZEE with another Tirzepatide-containing product or another GLP-1 receptor agonist unless specifically instructed by your healthcare professional.
If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before using TIRZEE.
Tirzepatide is generally not recommended for weight-loss treatment during pregnancy, because intentional weight loss is not recommended during pregnancy.
If pregnancy occurs while using Tirzepatide, contact your healthcare provider promptly.
Because TIRZEE is temperature sensitive, proper storage is essential.
TIRZEE 15MG/0.5ML is temperature sensitive and is currently only deliverable in Lahore through SuperCare Pharma.
Proper cold-chain handling is important to maintain product quality.
Contains Tirzepatide, a dual GIP and GLP-1 receptor agonist.
Designed for patients who have been prescribed the 15mg dose following appropriate treatment escalation.
Provides a convenient injectable format for weekly administration.
TIRZEE 15MG/0.5ML is manufactured by Getz Pharma.
Because this medicine is temperature sensitive, appropriate storage and handling are essential.
Sample/Placeholder Reviews – For Demonstration Only
⭐⭐⭐⭐⭐ Ali R. – Lahore
“Ordered my prescribed TIRZEE pen through SuperCare Pharma. It arrived properly packed and in good condition.”
⭐⭐⭐⭐⭐ Usman K. – Lahore
“The ordering process was convenient and the temperature-sensitive product was handled carefully.”
⭐⭐⭐⭐⭐ Hassan M. – Lahore
“Good online pharmacy experience and the product arrived securely packaged.”
TIRZEE 15MG/0.5ML Prefilled Pen contains Tirzepatide and is a prescription injectable medicine used for appropriate patients with type 2 diabetes and/or chronic weight management, depending on the applicable indication.
Tirzepatide works through dual GIP and GLP-1 receptor activity, helping regulate blood glucose, appetite, and food intake.
The 15mg strength should only be used according to a healthcare professional's prescribed treatment plan. Common side effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting, constipation, and decreased appetite.
TIRZEE 15MG/0.5ML is temperature sensitive and only deliverable in Lahore through SuperCare Pharma.
Prescription medicine – use only under qualified medical supervision.
TIRZEE contains Tirzepatide and may be prescribed for type 2 diabetes and/or chronic weight management in eligible patients, depending on the approved indication and medical advice.
No. The 15mg strength is a higher Tirzepatide dose and is generally reached through gradual dose escalation when prescribed. It should not be started without medical supervision.
Tirzepatide is administered once weekly according to the treatment schedule prescribed by your healthcare professional.
Yes. TIRZEE is a temperature-sensitive medicine and must be stored and transported according to the manufacturer's recommended conditions. SuperCare Pharma currently delivers this product only in Lahore.
TIRZEE 15MG/0.5ML Prefilled Pen by Getz Pharma can be ordered from SuperCare Pharma, subject to prescription and product availability. Due to its temperature-sensitive nature, delivery is currently limited to Lahore.
Choose SuperCare Pharma for a convenient and reliable online pharmacy experience in Pakistan.
✔ Genuine pharmaceutical products
✔ Secure online ordering
✔ Temperature-sensitive product handling
✔ Carefully packed orders
✔ Lahore delivery for TIRZEE
✔ Competitive prices
✔ Dedicated customer support
✔ Convenient online pharmacy service
Looking for TIRZEE 15MG/0.5ML Prefilled Pen by Getz Pharma? Order from SuperCare Pharma for convenient online ordering and temperature-sensitive delivery in Lahore.
Because TIRZEE is a prescription medicine, use it only according to your healthcare professional's treatment plan.
